CareDx (CDNA) Misses Q1 EPS by 1c

CareDx (NASDAQ: CDNA) reported Q1 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $6.8 million.

Cash and cash equivalents were $39.0 million as of March 31, 2015 compared to $36.4 million as of December 31, 2014. This represents an increase of $2.6 million, primarily as a result of a modest cash burn rate of approximately $1.4 million offset by the proceeds from refinancing a previous loan into a larger term loan facility.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• CareDx to present 30+ abstracts at 2026 American Transplant Congress
• Middleby board approves spin-off of food processing unit Midera